260 related articles for article (PubMed ID: 21298036)
1. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer.
Baird AM; Gray SG; O'Byrne KJ
PLoS One; 2011 Jan; 6(1):e14593. PubMed ID: 21298036
[TBL] [Abstract][Full Text] [Related]
2. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
[TBL] [Abstract][Full Text] [Related]
3. IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.
Baird AM; Gray SG; O'Byrne KJ
Eur J Cancer; 2011 Aug; 47(12):1908-18. PubMed ID: 21565488
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.
Sun H; Chung WC; Ryu SH; Ju Z; Tran HT; Kim E; Kurie JM; Koo JS
Cancer Prev Res (Phila); 2008 Oct; 1(5):316-28. PubMed ID: 19138976
[TBL] [Abstract][Full Text] [Related]
5. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
[TBL] [Abstract][Full Text] [Related]
6. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
7. Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools.
Unver N
Med Oncol; 2021 May; 38(6):68. PubMed ID: 33983509
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
[TBL] [Abstract][Full Text] [Related]
9. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
[TBL] [Abstract][Full Text] [Related]
10. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling.
Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A
Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807
[TBL] [Abstract][Full Text] [Related]
11. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
[TBL] [Abstract][Full Text] [Related]
12. ELR+-CXC chemokines and their receptors in early metanephric development.
Levashova ZB; Sharma N; Timofeeva OA; Dome JS; Perantoni AO
J Am Soc Nephrol; 2007 Aug; 18(8):2359-70. PubMed ID: 17634442
[TBL] [Abstract][Full Text] [Related]
13. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
[TBL] [Abstract][Full Text] [Related]
14. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
Ahuja SK; Murphy PM
J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
[TBL] [Abstract][Full Text] [Related]
15. ELR+ CXC chemokines in human milk.
Maheshwari A; Christensen RD; Calhoun DA
Cytokine; 2003 Nov; 24(3):91-102. PubMed ID: 14581003
[TBL] [Abstract][Full Text] [Related]
16. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
[TBL] [Abstract][Full Text] [Related]
17. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431.
Metzner B; Hofmann C; Heinemann C; Zimpfer U; Schraufstätter I; Schöpf E; Norgauer J
Oncol Rep; 1999; 6(6):1405-10. PubMed ID: 10523720
[TBL] [Abstract][Full Text] [Related]
19. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
